Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
At age 50, you can make catch-up contributions to enhance your retirement savings. Understand how to take full advantage of this opportunity.
9,259 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
SpaceX may be the headline grabber, but buying on day one isn’t a slam-dunk. This guide gives you three essential que...
This guide dives into Arbe's Q2 2025 earnings, decoding revenue growth, margins, and guidance. Learn actionable ways ...
Discover how to read arbe (arbe) 2025 earnings from the Q4 transcript, uncover management priorities, and turn insigh...
Bitcoin retraced after a volatile stretch, pushing traders to rethink income-focused strategies. This piece breaks do...
In 2026, a rising rate environment and tighter underwriting are driving HELOC denials. This report explains how to re...
Charles Schwab stock bumping higher today caught investors' attention as May metrics showed record asset inflows. Thi...
A retiree paid off her mortgage with a lump-sum 401(k) withdrawal, only to see Medicare IRMAA add $487 to her monthly...
A sharp drop in Planet Labs shares sparked questions about growth, cash burn, and contract momentum. This guide break...
Futures markets show how traders see the near-term path for oil, stocks, and currencies. This explainer breaks down t...
SpaceX stock just opened with an eye-catching $150 price, an 11% jump from the IPO price of $135. This article breaks...
SpaceX’s public debut reframes who wins in venture capital, with Founders Fund and Andreessen Horowitz among the marq...